Shopping Cart
Remove All
Your shopping cart is currently empty
DDX3-IN-2 is an ATP-dependent RNA deconjugase (DDX3) inhibitor with broad-spectrum antiviral activity and is used in the study of HIV infection and dengue virus infection.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $149 | - | In Stock |
| Description | DDX3-IN-2 is an ATP-dependent RNA deconjugase (DDX3) inhibitor with broad-spectrum antiviral activity and is used in the study of HIV infection and dengue virus infection. |
| Targets&IC50 | DEADbox polypeptide 3 (DDX3):0.3 μM |
| In vitro | DDX3-IN-2 is a competitive inhibitor of RNA substrates, and its inhibitory potency decreases with increasing RNA substrate concentration. DDX3-IN-2 was shown to be a potent inhibitor of DEADbox polypeptide 3 (DDX3) with an IC50 of 0.3 μM, and DDX3-IN-2 was inactive against the ATPase activity of DDX3, DDX1 deconjugating enzyme and DENV NS3 deconjugating enzyme. [1] |
| In vivo | In animal studies, DDX3-IN-2 was administered via tail vein injection at a dose of 20 mg/kg, which showed good biocompatibility and was well tolerated by Wistar rats. DDX3-IN-2 rapidly shortens the half-life and decreases plasma clearance in an intravenous push (0-25 hours) at a dose of 10 mg/kg. [1] |
| Molecular Weight | 349.43 |
| Formula | C20H23N5O |
| Cas No. | 1919828-81-1 |
| Smiles | O=C(NC1=CC=C(C=C1)N2N=NC(=C2)CCCC)NC=3C=CC=CC3C |
| Color | White |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (228.94 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+90% Corn Oil: 3.3 mg/mL (9.44 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.